Cart
sales@molnova.com
Etebenecid
CAS No. 1213-06-5
Etebenecid( Urelim )
Catalog No. M26681 CAS No. 1213-06-5
Etebenecid is uricosuric agents, which lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | 28 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEtebenecid
-
NoteResearch use only, not for human use.
-
Brief DescriptionEtebenecid is uricosuric agents, which lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys.
-
DescriptionEtebenecid is uricosuric agents, which lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys. It also inhibits penicillin tubular secretion.
-
In Vitro——
-
In Vivo——
-
SynonymsUrelim
-
PathwayOthers
-
TargetOther Targets
-
Recptorprostaglandin F2α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1213-06-5
-
Formula Weight257.3
-
Molecular FormulaC11H15NO4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (971.59 mM)
-
SMILESCCN(CC)S(=O)(=O)c1ccc(cc1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Vallera C, et al. Uterotonic Medications: Oxytocin, Methylergonovine, Carboprost, Misoprostol. Anesthesiol Clin. 2017 Jun;35(2):207-219.
molnova catalog
related products
-
BRCA1-IN-2
BRCA1-IN-2 is a cell membrane-crossing BRCA1 protein-protein interaction (PPI) inhibitor with antitumor activity that acts by disrupting the interaction of BRCA1 (BRCT)2 with proteins.
-
XMP
XMP is an intermediate in purine metabolism.
-
(R)-Mephenytoin
(R)-Mephenytoin ((–)-Mephenytoin) is the the R-enantiomer of Mephenytoin which is an anticonvulsant agent.
